Filters close
Newswise:Video Embedded endurance-exercise-without-weight-loss-may-reduce-body-fat
VIDEO
Released: 18-Sep-2024 7:00 AM EDT
Endurance Exercise without Weight Loss May Reduce Body Fat
American Physiological Society (APS)

Participating in a high volume of exercise over a short period of time, such as cycling hundreds of miles in a few days, could reduce body fat levels without weight loss. The first-of-its-kind study is published ahead of print in the American Journal of Physiology-Endocrinology and Metabolism and has been chosen as an APSselect article for September.

Released: 18-Sep-2024 6:05 AM EDT
Mude O Seu Estilo De Vida Para Reduzir Seu Risco De Desenvolver CâNcer: Especialista Da Mayo Clinic Explica Como
Mayo Clinic

Cerca de um terço da metade dos casos de câncer são evitáveis, de acordo com a Organização Mundial Da Saúde. O Dr. Jon Ebbert, diretor médico do Centro de Dependência de Nicotina da Mayo Clinic, diz que nunca é tarde demais para fazer mudanças no estilo de vida que possam diminuir o seu risco de desenvolver câncer.

Released: 18-Sep-2024 6:00 AM EDT
Cambie su estilo de vida para reducir su riesgo de desarrollar cáncer: un experto de Mayo Clinic explica cómo
Mayo Clinic

Aproximadamente un tercio de la mitad de los casos de cáncer se pueden prevenir, según la Organización Mundial de la Salud. El Dr. Jon Ebbert, director médico del Centro de Adicción a la Nicotina de Mayo Clinic, dice que nunca es demasiado tarde para hacer cambios en el estilo de vida que puedan disminuir su riesgo de desarrollar cáncer.

Released: 18-Sep-2024 3:05 AM EDT
تغيير نمط الحياة يقلل خطر الإصابة بالسرطان: يشرح خبير مايو كلينك الكيفية
Mayo Clinic

روتشستر، ولاية مينيسوتا — يمكن الوقاية من حوالى ثلث إلى نصف حالات السرطان، وذلك وفقًا لتصريح منظمة الصحة العالمية. يقول جون إيبرت، دكتور في الطب، المدير الطبي لمركز علاج إدمان النيكوتين، أنه لم يفت الأوان أبدًا لإجراء تغييرات في نمط الحياة والتي من شأنها تقليل خطر الإصابة بمرض السرطان.

Released: 17-Sep-2024 8:05 PM EDT
Studies Deepen Understanding of LGBTQ Health Disparities
Harvard Medical School

Three new studies pinpoint challenges and opportunities for closing health disparities for LGBTQ+ people, showing how the convergence of political and social environments, structural inequities, and implicit and explicit bias within the medical system erode LGBTQ+ well-being.

17-Sep-2024 1:30 PM EDT
Novel Triplet Regimen Yields Promising Response in Advanced-Phase Chronic Myeloid Leukemia
University of Texas MD Anderson Cancer Center

According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or relapsed/refractory advanced-phase chronic myeloid leukemia (CML) – including both accelerated or myeloid blast phases of the disease – or Philadelphia chromosome-positive acute myeloid leukemia (AML) achieved a bone marrow remission when treated with a novel combination of decitabine, venetoclax and ponatinib.

Newswise: 1920_dengue-fever-cedars-sinai.jpg?10000
Released: 17-Sep-2024 5:05 PM EDT
Dengue Fever Lands in LA: How Global Warming Is Affecting Health
Cedars-Sinai

Amid southern california’s recent record-breaking heat wave and fast-moving wildfires, public health officials reported the third locally acquired case of dengue fever in the los angeles area. Although the events seem unrelated, they actually are connected—and for troubling reasons.

Newswise: LJI Discovery Paves the Way for Antivirals Against Ebola Virus and Its Deadly Relatives
Released: 17-Sep-2024 5:05 PM EDT
LJI Discovery Paves the Way for Antivirals Against Ebola Virus and Its Deadly Relatives
La Jolla Institute for Immunology

The new study, led by researchers in the Saphire Lab at LJI, reveals the inner workings of the Ebola virus nucleocapsid. LA JOLLA, CA—At this moment, the world has few tools to combat deadly filoviruses, such as Ebola and Marburg viruses. The only approved vaccine and antibody treatments protect against just one filovirus species.

Newswise: Mount Sinai Expert Available to Discuss Collaborative Partnerships in Global Health
Released: 17-Sep-2024 4:40 PM EDT
Mount Sinai Expert Available to Discuss Collaborative Partnerships in Global Health
Mount Sinai Health System

Renowned expert in building global health partnerships and HIV care to speak at the 2024 Concordia Annual Summit

Newswise: NationalGeographic_2797656.jpg?w=2560&h=1700
Released: 17-Sep-2024 4:05 PM EDT
It's Not Your Life Span You Need to Worry About. It's Your Health Span.
Hevolution Foundation

We’re living much longer than our ancestors, but is that always a good thing? With many people living well into our late 70s or beyond, more of us are also spending a greater portion of our lives—sometimes a decade or more—saddled with physical and mental health conditions that can make it challenging to accomplish the tasks of daily life.

   
Newswise: morimoto970__FitMaxWzk3MCw2NTBd.jpg
Released: 17-Sep-2024 4:05 PM EDT
Northwestern receives $32.4 million to study healthy aging
Hevolution Foundation

Northwestern University has been awarded $32.4 million over five years from the Hevolution Foundation to study proteostasis — the processes by which cells maintain protein health for good overall health and to prevent diseases of protein misfolding. A key goal is to improve the health people experience as they age, particularly in their final years.

   
Newswise: FDA Approval of New Drug Regimen Helps Reduce Risk of Breast Cancer Recurrence for Patients with Early-Stage Disease
Released: 17-Sep-2024 4:05 PM EDT
FDA Approval of New Drug Regimen Helps Reduce Risk of Breast Cancer Recurrence for Patients with Early-Stage Disease
University of California, Los Angeles (UCLA), Health Sciences

Teri Boudreaux was one of more than 5,000 women who joined a clinical trial that was looking at the benefit of adding the targeted therapy drug ribociclib to conventional hormonal therapy for the adjuvant treatment of HR-positive, HER2-negative early-stage breast cancer. I

Newswise: Biopole-SA-2048x742.jpg
Released: 17-Sep-2024 4:05 PM EDT
Vandria Closes Series a Round at CHF28.3m
Hevolution Foundation

Hevolution Foundation and Dolby Family Ventures led Vandria’s Series A closing, bringing the capital to CHF 28.3. With the money, the 2021 EFPL spin-out aims to advance its first in class mitophagy inducer VNA-318 that targets several neurodegenerative indications into clinical development.

     
Released: 17-Sep-2024 4:05 PM EDT
How Targeting 'Zombie Cells' Could Help Extend Healthspan
Hevolution Foundation

What if a drug could help you live a longer, healthier life? Scientists at the University of Connecticut are working on it. In a new study in Cell Metabolism, researchers described how to target specific cells to extend the lifespan and improve the health of mice late in life.

   
Newswise: Wistar Institute Researchers Identify Parkinson-related Protein’s Role in Cancer and T Cell Activation
Released: 17-Sep-2024 2:05 PM EDT
Wistar Institute Researchers Identify Parkinson-related Protein’s Role in Cancer and T Cell Activation
Wistar Institute

Wistar scientists have demonstrated the role of Parkin — a protein implicated in Parkinson's disease — in the body’s innate immune response to cancer.

Newswise: Martin-Lab3-Banner.jpg
Released: 17-Sep-2024 2:05 PM EDT
UM School of Medicine Aims to Accelerate Basic Science Research and Advance Drug Therapies with Newly-Created Department
University of Maryland School of Medicine

University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, has announced the formation of a new Department of Pharmacology, Physiology and Drug Development, which merges the Department of Physiology and Department of Pharmacology. This new Department aligns the basic science research efforts of both entities with a strong emphasis on the development of new drug therapies.

Newswise: Scientists at The Wistar Institute Clone Several New Anti-Interferon Antibodies - Developing Future Therapeutic Candidates with Broad Application Potential
Released: 17-Sep-2024 2:05 PM EDT
Scientists at The Wistar Institute Clone Several New Anti-Interferon Antibodies - Developing Future Therapeutic Candidates with Broad Application Potential
Wistar Institute

Wistar Institute scientists have successfully isolated and cloned fully human antibodies that can block specific Type-I interferon molecules in vitro; their discovery has an array of potential clinical & research applications, enabling scientists with a new way to investigate the role of specific Type-I interferons in a variety of diseases.

   
Newswise: Two Common Surgeries Equally Effective for Treating Blinding Condition of the Eyelid
10-Sep-2024 4:05 PM EDT
Two Common Surgeries Equally Effective for Treating Blinding Condition of the Eyelid
NIH, National Eye Institute (NEI)

Trachomatous trichiasis, a potentially blinding condition where inward-turned eyelashes scratch the front of the eye, can successfully be treated by either of the two most common types of eyelid surgery, according to findings from a large comparison trial funded by the National Institutes of Health.

Newswise: National Chiropractic Health Month to Promote Musculoskeletal Health for Aging Well
Released: 17-Sep-2024 1:05 PM EDT
National Chiropractic Health Month to Promote Musculoskeletal Health for Aging Well
American Chiropractic Association

ACA and chiropractors nationwide will celebrate National Chiropractic Health Month this October with the theme “Plan for a Strong Healthspan,” raising awareness of the importance of a strong musculoskeletal (MSK) system for healthy aging.

Newswise: Ultra-Low-Dose Ketamine Can Curb Opioid Withdrawal
Released: 17-Sep-2024 1:05 PM EDT
Ultra-Low-Dose Ketamine Can Curb Opioid Withdrawal
University of Washington School of Medicine and UW Medicine

Research findings published Aug. 29 in Addiction Science & Clinical Practice may offer hope. A pilot study showed that a small amount of ketamine can reduce or eliminate the withdrawal symptoms associated with quitting fentanyl.



close
0.25551